La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Substantia Nigra (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Substantia Nigra (diagnostic imaging) < Substantia Nigra (drug effects) < Substantia Nigra (embryology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000033 (1999) O K Hassani [France] ; J. FégerEffects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
000103 (2000) E C Hirsch [France]Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
000177 (2001) A. Hartmann [France] ; J D Troadec ; S. Hunot ; K. Kikly ; B A Faucheux ; A. Mouatt-Prigent ; M. Ruberg ; Yves Agid [France] ; E C HirschCaspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.
000179 (2001) H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C HirschCaspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000217 (2001) O K Hassani [France] ; M. Mouroux ; G A Bohme ; J M Stutzmann ; J. FégerRiluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.
000223 (2002) Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta ImperatoNeuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000240 (2002) Christelle Gouhier [France] ; Sylvie Chalon ; Anne Aubert-Pouessel ; Marie-Claire Venier-Julienne ; Christophe Jollivet ; Jean-Pierre Benoit ; Denis GuilloteauProtection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
000256 (2002) Aïcha Douhou [France] ; Thomas Debeir ; Mario Gustavo Murer ; Louis Do ; Noëlle Dufour ; Véronique Blanchard ; Saliha Moussaoui ; Georg Andrees Bohme ; Yves Agid [France] ; Rita Raisman-VozariEffect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice.
000293 (2002) L. Cathala [France] ; A. Guyon ; D. Eugene ; D. Paupardin-TritschAlpha2-adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra.
000A59 (1990) Yves Agid [France] ; A M Graybiel ; M. Ruberg ; E. Hirsch ; J. Blin ; B. Dubois ; F. Javoy-AgidThe efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
000D60 (2012) Mickael Decressac [France] ; Stéphanie Pain ; Pierre-Yves Chabeauti ; Laura Frangeul ; Nathalie Thiriet ; Herbert Herzog ; Jackie Vergote ; Sylvie Chalon ; Mohamed Jaber ; Afsaneh GaillardNeuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
001073 (2014) G. Drui [France] ; S. Carnicella [France] ; C. Carcenac [France] ; M. Favier [France] ; A. Bertrand [France] ; S. Boulet [France] ; M. Savasta [France]Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.
001111 (2013) M. Lagière [France] ; S. Navailles ; L. Mignon ; A. Roumegous ; M-F Chesselet ; P. De DeurwaerdèreThe enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates.
001318 (2014) Maxime Assous [France] ; Laurence Had-Aissouni [France] ; Paolo Gubellini [France] ; Christophe Melon [France] ; Imane Nafia [France] ; Pascal Salin [France] ; Lydia Kerkerian-Le-Goff [France] ; Philippe Kachidian [France]Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra.
001406 (2014) Franziska Richter [États-Unis] ; Fuying Gao [États-Unis] ; Vera Medvedeva [États-Unis] ; Patrick Lee [États-Unis] ; Nicholas Bove [États-Unis] ; Sheila M. Fleming [États-Unis] ; Magali Michaud [France] ; Vincent Lemesre [États-Unis] ; Stefano Patassini [États-Unis] ; Krystal De La Rosa [États-Unis] ; Caitlin K. Mulligan [États-Unis] ; Pedrom Sioshansi [États-Unis] ; Chunni Zhu [États-Unis] ; Giovanni Coppola [États-Unis] ; Thierry Bordet [France] ; Rebecca Pruss [France] ; Marie-Françoise Chesselet [États-Unis]Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
001409 (2014) Anissa El Arfani [Belgique] ; Eduard Bentea [Belgique] ; Najat Aourz [Belgique] ; Ben Ampe [Belgique] ; Philippe De Deurwaerdère [France] ; Ann Van Eeckhaut [Belgique] ; Ann Massie [Belgique] ; Sophie Sarre [Belgique] ; Ilse Smolders [Belgique] ; Yvette Michotte [Belgique]NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
001436 (2014) Wisam Dieb [France] ; Omar Ouachikh [France] ; Franck Durif [France] ; Aziz Hafidi [France]Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia
001740 (2015) W. Peelaerts [Belgique] ; L. Bousset [France] ; A. Van Der Perren [Belgique] ; A. Moskalyuk [Belgique] ; R. Pulizzi [Belgique] ; M. Giugliano [Belgique] ; C. Van Den Haute [Belgique] ; R. Melki [France] ; V. Baekelandt [Belgique]α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
001741 (2015) Hyung-Wook Kim [États-Unis, Corée du Sud] ; Won-Seok Choi [États-Unis, Corée du Sud] ; Noah Sorscher [États-Unis] ; Hyung Joon Park [Corée du Sud] ; François Tronche [France] ; Richard D. Palmiter [États-Unis] ; Zhengui Xia [États-Unis]Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo
001875 (2015) Nicolas Maurice [France] ; Thierry Deltheil [France] ; Christophe Melon [France] ; Bertrand Degos [France] ; Christiane Mourre [France] ; Marianne Amalric [France] ; Lydia Kerkerian-Le Goff [France]Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson’s Disease
001930 (2016) Ludovico Arcuri [Italie] ; Riccardo Viaro [Italie] ; Simone Bido [Italie] ; Francesco Longo [Italie] ; Mariangela Calcagno [Italie] ; Pierre-Olivier Fernagut [France] ; Nurulain T. Zaveri [États-Unis] ; Girolamo Cal [Italie] ; Erwan Bezard [France] ; Michele Morari [Italie]Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Substantia Nigra (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Substantia Nigra (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Substantia Nigra (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024